Figures computed from official regulatory filings — .
Analysttarget 225 USD (+3040441%) · consensus 4/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 0% · institutions 0% · short 11.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Evofem Biosciences, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
39 buys37 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Zhang Yan | Sell | $4.2 | SEC | ||
| Kamdar Kim P. |
| Sell |
| $6.2 |
| SEC |
| File Justin J. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PELLETIER SAUNDRA Ltrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PELLETIER SAUNDRA Ltrack record | Buy | $49.4K | conv 65 | SEC |
| Greer Gillian | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rarick Lisa Dale | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kamdar Kim P.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rutherford Colin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| O'Brien Anthony Stephen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fitzpatrick Alexander Atrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PELLETIER SAUNDRA Ltrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| File Justin J. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| File Justin J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fitzpatrick Alexander Atrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PELLETIER SAUNDRA Ltrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PELLETIER SAUNDRA Ltrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fitzpatrick Alexander Atrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| File Justin J. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| File Justin J. | Buy | $15K | conv 53Cluster | SEC |
| Fitzpatrick Alexander Atrack record | Buy | $9.8K | conv 48Cluster | SEC |
| PELLETIER SAUNDRA Ltrack record | Buy | $51.3K | conv 55Cluster | SEC |
| Barrans Russelltrack record | Other | $19.6K | SEC |
| Kamdar Kim P.track record | Buy | $11.7K | conv 61ClusterFirst in 12mo | SEC |
| O'Brien Anthony Stephen | Buy | $10.7K | conv 77ClusterFirst in 12mo | SEC |